Drug Approval | January 26, 2024
Strides receives USFDA approval for Pregabalin Capsules
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
Pregabalin Capsules have an estimated market size of US $244 million for twelve months ending Sep 2022 according to IQVIA
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
The consideration for the medicines in India is valued at Rs 180.48 crore
Adjusted PAT declined 18.8% YoY
Subscribe To Our Newsletter & Stay Updated
